M 735 (Benazepril hydrochloride and hydrochlorothiazide 10 mg / 12.5 mg)
Pill imprint M 735 has been identified as Benazepril hydrochloride and hydrochlorothiazide 10 mg / 12.5 mg.
Benazepril/hydrochlorothiazide is used in the treatment of high blood pressure and belongs to the drug class ACE inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Benazepril/hydrochlorothiazide 10 mg / 12.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- M 735
- 10 mg / 12.5 mg
- 10.00 mm
- Prescription only
- Drug Class:
- ACE inhibitors with thiazides
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose anhydrous
ferric oxide yellow
Note: Inactive ingredients may vary.
|NDC Code||Manufacturer / Repackager|
|33358-0047||CorePharma, LLC (repackager)|
More about benazepril/hydrochlorothiazide
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- En Español
- 1 Review – Add your own review/rating
- Drug class: ACE inhibitors with thiazides
- Hydrochlorothiazide and benazepril
- Benazepril and hydrochlorothiazide (Advanced Reading)
Other brands: Lotensin HCT
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.